We are live on ! Find out more
HHMI

Howard Hughes Medical Institute Portfolio holdings

AUM $416M
1-Year Est. Return 13.82%
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$630M
AUM Growth
+$164M
Cap. Flow
+$134M
Cap. Flow %
21.24%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$132M
2
BIOA
BioAge Labs
BIOA
+$2.28M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$628M 99.62%
1,094,663
+238,000
+28% +$132M
BIOA
2
BioAge Labs
BIOA
$524M
$2.37M 0.38%
+113,765
New +$2.28M

Similar funds

Howard Hughes Medical Institute's Q3 2024 Portfolio in Review

As of Q3 2024, Howard Hughes Medical Institute held 2 positions worth $630M, up 35% from $466M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Howard Hughes Medical Institute deployed $134M of net new capital in Q3 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was BioAge Labs: 113,765 shares worth $2.37M.

By sector, the portfolio is most concentrated in Healthcare at 0.38% of assets.

  • Howard Hughes Medical Institute's largest Q3 2024 buy was BioAge Labs: 113,765 shares worth $2.37M.
  • Howard Hughes Medical Institute added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $132M increase.
  • Howard Hughes Medical Institute's ten largest holdings make up 100% of its $630M portfolio in Q3 2024.
  • Howard Hughes Medical Institute opened 1 new position and closed 0 in Q3 2024.
  • Howard Hughes Medical Institute's portfolio value rose 35% quarter-over-quarter to $630M.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2024, filed 14 Nov 2024.